Anti-Mullerian Hormone and Fertility Treatment Decisions in Polycystic Ovary Syndrome: A Literature Review.

Q2 Medicine

Journal of Human Reproductive Sciences Pub Date : 2024-01-01 Epub Date: 2024-03-28 DOI:10.4103/jhrs.jhrs_153_23

Duru Shah, Padma Rekha Jirge

引用次数: 0

Abstract

Anti-Mullerian hormone is a robust marker of ovarian reserve and ovarian response in in vitro fertilisation (IVF). However, its role extends beyond improving the safety of IVF by aiding in choosing appropriate protocols and dosing. This review looks at the value of pre-treatment anti-Mullerian hormone (AMH) value in choosing the appropriate modality of treatment and its predictive ability for the outcomes of such treatment. It briefly addresses the factors that may modulate AMH levels and make clinical decision-making challenging.

查看原文本刊更多论文

多囊卵巢综合征患者的抗苗勒管激素和生育治疗决定：文献综述。

抗穆勒氏管激素是体外受精（IVF）中卵巢储备和卵巢反应的有力标志。然而，抗苗勒氏管激素的作用不仅限于提高体外受精的安全性，还有助于选择合适的方案和剂量。本综述探讨了治疗前抗穆勒氏管激素（AMH）值在选择适当治疗方式中的价值及其对治疗结果的预测能力。它简要讨论了可能调节 AMH 水平并使临床决策具有挑战性的因素。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Human Reproductive Sciences Medicine-Reproductive Medicine

CiteScore

2.60

自引率

0.00%

发文量

审稿时长

23 weeks

期刊介绍： The Journal of Human Reproductive Sciences (JHRS) (ISSN:0974-1208) a Quarterly peer-reviewed international journal is being launched in January 2008 under the auspices of Indian Society of Assisted Reproduction. The journal will cover all aspects human reproduction including Andrology, Assisted conception, Endocrinology, Physiology and Pathology, Implantation, Preimplantation Diagnosis, Preimplantation Genetic Diagnosis, Embryology as well as Ethical, Legal and Social issues. The journal will publish peer-reviewed original research papers, case reports, systematic reviews, meta-analysis, and debates.